Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial

IMPORTANCE: Meropenem-vaborbactam is a combination carbapenem/beta-lactamase inhibitor and a potential treatment for severe drug-resistant gram-negative infections. OBJECTIVE: To evaluate efficacy and adverse events of meropenem-vaborbactam in complicated urinary tract infection (UTI), including acu...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:JAMA
Κύριοι συγγραφείς: Kaye, Keith S., Bhowmick, Tanaya, Metallidis, Symeon, Bleasdale, Susan C., Sagan, Olexiy S., Stus, Viktor, Vazquez, Jose, Zaitsev, Valerii, Bidair, Mohamed, Chorvat, Erik, Dragoescu, Petru Octavian, Fedosiuk, Elena, Horcajada, Juan P., Murta, Claudia, Sarychev, Yaroslav, Stoev, Ventsislav, Morgan, Elizabeth, Fusaro, Karen, Griffith, David, Lomovskaya, Olga, Alexander, Elizabeth L., Loutit, Jeffery, Dudley, Michael N., Giamarellos-Bourboulis, Evangelos J.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Medical Association 2018
Θέματα:
Original Investigation
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838656/
https://ncbi.nlm.nih.gov/pubmed/29486041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.0438
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια